STOCK TITAN

HRaspirin, Ltd. is Pleased to Announce that its Documentation Management System is in Final Testing and Customer Trials

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

HRaspirin, a subsidiary of Star Alliance International Corp. (OTC PINK:STAL), is in the final testing phase of its new HRADocs program, an electronic signature and document management system. The product, initially developed for exclusive client use, has evolved into a robust platform that will be offered to businesses and individuals at competitive prices. Key features include:

  • Unlimited users and data points
  • Document tracking and archived progression
  • Customizable dashboard
  • Attachment integration

The global digital signature market was valued at approximately $5.3 Billion in 2023, growing over 50% since the COVID-19 pandemic. HRaspirin aims to launch the final product in September, targeting a share of this expanding market with its competitive pricing and unique advantages.

HRaspirin, una sussidiaria di Star Alliance International Corp. (OTC PINK:STAL), è nella fase finale di test del suo nuovo programma HRADocs, un sistema di gestione documentale e firma elettronica. Il prodotto, inizialmente sviluppato per l'uso esclusivo dei clienti, è evoluto in una piattaforma robusta che sarà offerta a aziende e privati a prezzi competitivi. Caratteristiche principali includono:

  • Utenti e punti dati illimitati
  • Tracciamento dei documenti e progressione archiviata
  • Dashboard personalizzabile
  • Integrazione degli allegati

Il mercato globale delle firme digitali è stato valutato a circa 5,3 miliardi di dollari nel 2023, con una crescita di oltre il 50% dalla pandemia di COVID-19. HRaspirin mira a lanciare il prodotto finale a settembre, puntando a conquistare una quota di questo mercato in espansione con prezzi competitivi e vantaggi unici.

HRaspirin, una subsidiaria de Star Alliance International Corp. (OTC PINK:STAL), se encuentra en la fase final de pruebas de su nuevo programa HRADocs, un sistema de gestión de documentos y firma electrónica. El producto, desarrollado inicialmente para el uso exclusivo de los clientes, ha evolucionado hacia una plataforma robusta que se ofrecerá a empresas e individuos a precios competitivos. Características clave incluyen:

  • Usuarios y puntos de datos ilimitados
  • Seguimiento de documentos y progreso archivado
  • Panel de control personalizable
  • Integración de archivos adjuntos

El mercado global de firmas digitales fue valorado en aproximadamente 5.3 mil millones de dólares en 2023, creciendo más del 50% desde la pandemia de COVID-19. HRaspirin tiene como objetivo lanzar el producto final en septiembre, apuntando a capturar una parte de este mercado en expansión con su precios competitivos y ventajas únicas.

HRaspirin은 Star Alliance International Corp. (OTC PINK:STAL)의 자회사로, 새로운 HRADocs 프로그램의 최종 테스트 단계에 있습니다. 이 프로그램은 전자 서명 및 문서 관리 시스템입니다. 처음에는 고객 전용으로 개발되었으나, 이제는 기업과 개인에게 경쟁력 있는 가격으로 제공될 강력한 플랫폼으로 발전했습니다. 주요 특징은 다음과 같습니다:

  • 무제한 사용자 및 데이터 포인트
  • 문서 추적 및 보관 진행 상황
  • 사용자 정의 가능한 대시보드
  • 첨부파일 통합

글로벌 디지털 서명 시장은 2023년에 약 53억 달러로 평가되었으며, COVID-19 팬데믹 이후 50% 이상 성장했습니다. HRaspirin은 9월에 최종 제품을 출시할 계획이며, 경쟁력 있는 가격과 독특한 장점으로 이 확장하는 시장의 점유율을 목표로 하고 있습니다.

HRaspirin, une filiale de Star Alliance International Corp. (OTC PINK:STAL), est en phase de test finale de son nouveau programme HRADocs, un système de gestion de documents et de signature électronique. Le produit, développé initialement pour un usage exclusif des clients, a évolué vers une plateforme robuste qui sera proposée aux entreprises et aux particuliers à des prix compétitifs. Les caractéristiques clés comprennent :

  • Utilisateurs et points de données illimités
  • Suivi des documents et progression archivée
  • Tableau de bord personnalisable
  • Intégration des pièces jointes

Le marché mondial de la signature numérique a été évalué à environ 5,3 milliards de dollars en 2023, avec une croissance de plus de 50 % depuis la pandémie de COVID-19. HRaspirin vise à lancer le produit final en septembre, visant à capter une part de ce marché en expansion avec ses prix compétitifs et ses avantages uniques.

HRaspirin, eine Tochtergesellschaft von Star Alliance International Corp. (OTC PINK:STAL), befindet sich in der finalen Testphase seines neuen HRADocs-Programms, einem System für elektronische Signaturen und Dokumentenmanagement. Das Produkt, das ursprünglich für die exklusive Nutzung durch Kunden entwickelt wurde, hat sich zu einer robusten Plattform entwickelt, die Unternehmen und Privatpersonen zu wettbewerbsfähigen Preisen angeboten wird. Hauptmerkmale sind:

  • Unbegrenzte Nutzer und Datenpunkte
  • Dokumentenverfolgung und archivierte Fortschritte
  • Anpassbares Dashboard
  • Integrationsmöglichkeiten für Anhänge

Der globale Markt für digitale Signaturen wurde im Jahr 2023 auf etwa 5,3 Milliarden Dollar geschätzt und ist seit der COVID-19-Pandemie um über 50% gewachsen. HRaspirin plant, das endgültige Produkt im September auf den Markt zu bringen und zielt darauf ab, Anteile an diesem wachsenden Markt mit wettbewerbsfähigen Preisen und einzigartigen Vorteilen zu gewinnen.

Positive
  • HRADocs program entering final testing and customer trials phase
  • Planned launch of HRADocs to the public in September
  • Competitive pricing strategy for HRADocs compared to existing market offerings
  • Expansion of potential customer base beyond exclusive clients to businesses and individuals
Negative
  • None.

LAS VEGAS, NV / ACCESSWIRE / July 24, 2024 / Star Alliance International Corp. (OTC PINK:STAL), ("STAR or the Company"). STAR is pleased to confirm that HRaspirin is testing its new and exciting HRADocs program that offers electronic signatures plus a document management system.

Originally prepared to be part of their exclusive software system offered to clients, the program has been developed into a robust platform that will be offered directly to businesses and individuals at prices that are more economical than its competition. We anticipate introducing the final product in September.

The global digital signature market was valued at approximately $5.3 Billion in 2023, having grown by more than 50% since the onset of the COVID-19 pandemic. With HRA Docs, HRaspirin aims to build the most robust digital signature platform. The platform includes features such as unlimited users and data points, document tracking and archived progression, a customizable dashboard, and attachment integration.

Shawn Stephens, President of HRaspirin stated: "the introduction of https://www.hradocs.net is a big step to not only introduce this program to our current and future clients but to also offer it to the public. We feel confident that we will quickly gain customers for this exciting new product. Our product offers unique advantages at the most competitive prices in the current digital signature space."

Richard Carey, President and Chairman of Star Alliance International Corp., commented, "we continue to work on all our divisions but this new product which will be offered directly to the public is a big step for our Fintech division. Much more news coming. Keep watching this space."

About Star Alliance International Corp.

Star Alliance International Corp. ("the Company" or "STAL") was incorporated in the State of Nevada on April 17, 2014, under the laws of the State of Nevada.

Star Alliance International Corp. is a Worldwide Holding Company with a mine in California and other assets ready to be acquired. In addition, Star searches out innovative technologies that are eco-friendly including "Genesis," our environmentally safe gold and other mineral extraction system.

The Genesis extraction system extracts minerals from oxide and complex ores much faster than other processes in an environmentally safe manner. We plan to close this transaction as soon as possible.

We have also agreed terms to acquire controlling interests in two entities for our Fintech division and we are negotiating final terms for the acquisition of an interest in AIEnglishGPT, the artificial intelligence platform.

Our work on our digital asset, backed by gold, continues, as we prepare paperwork for regulatory approvals.

The Company anticipates continued expansion of our efforts domestically and abroad, with a particularly keen focus on mining technologies for precious metals and rare earth minerals, as well as other innovative technologies.

It is Star Alliance International Corp.'s goal to become an exciting well-rounded many-faceted company with a sophisticated corporate structure that allows for more transparency to our shareholders. Our planned diversification, paired with a sensible approach, will result in the absolute best possible outcomes and the highest possible value for our shareholders.

Safe Harbor and Informational Statement

This press release may contain forward-looking information within the meaning of Section 21E of the Security Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statement of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial conditions or results of operations; (iii): the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends.

The words "may", "would", "will", "expect", "estimate", "anticipate", "believe", "intend", and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statement is not a guarantee of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's statements and reports filed with the OTC Markets. The Company claims the safe harbor provided by Section 21E(c) of the Exchange Act for all forward-looking statements.

For more information, contact:

Anthony Anish, CFO, Star Alliance International Corp.
Telephone: 833-443-7827
E Mail: info@staralliancemines.com
Web Site: staralliancemines.com
Facebook, Linkedin,
Twitter @StarAllianceIn1

SOURCE: Star Alliance International Corp.



View the original press release on accesswire.com

FAQ

When is HRaspirin planning to launch its HRADocs program?

HRaspirin anticipates introducing the final HRADocs product in September 2024.

What are the key features of HRaspirin's HRADocs program?

HRADocs offers unlimited users and data points, document tracking and archived progression, a customizable dashboard, and attachment integration.

What was the value of the global digital signature market in 2023?

The global digital signature market was valued at approximately $5.3 Billion in 2023.

How does HRaspirin's HRADocs program aim to compete in the digital signature market?

HRADocs aims to compete by offering unique advantages at more economical prices compared to its competition in the digital signature space.

What is the stock symbol for Star Alliance International Corp., the parent company of HRaspirin?

The stock symbol for Star Alliance International Corp. is STAL, traded on the OTC PINK market.

STAR ALLIANCE INTL CORP

OTC:STAL

STAL Rankings

STAL Latest News

STAL Stock Data

687.05k
567.77M
13.23%
Gold
Basic Materials
Link
United States of America
Las Vegas